Aug 2026· Journal of Multidisciplinary Healthcare· Vol 19· 0 citations· 115 references
Medicine
TL;DR
Findings indicate that artificial intelligence can support the integration and analysis of multi-omics data, support the identification of genetic variants and disease associations, and improve predictive modeling for precision medicine.
Abstract
Purpose This review aimed to explore how artificial intelligence can be integrated with global genomic resources and to examine its implications for advancing precision medicine, with particular attention to population diversity, predictive modeling, and clinical translation. Methods A narrative review design was adopted, drawing on literature from major databases and supplementary search sources including PubMed, Scopus, Web of Science, IEEE Xplore, Embase, and Google Scholar. Studies were selected based on relevance to artificial intelligence applications in genomic data analysis and precision medicine. Key information from included studies was extracted using a structured narrative extraction framework and synthesized thematically to identify key patterns and emerging insights. Results A total of 54 studies were included in this review. The synthesis identified five recurring application areas: genomic data integration, variant and disease association detection, disease susceptibility and risk prediction, treatment response prediction, and clinical decision support. Findings indicate that artificial intelligence can support the integration and analysis of multi-omics data, support the identification of genetic variants and disease associations, and improve predictive modeling for precision medicine. Incorporating diverse population data was also reported to improve model generalizability and reduce bias. However, challenges related to data standardization, interoperability, ethical governance, overfitting in small or biased cohorts, limited prospective clinical validation, reproducibility, and clinical implementation remain significant barriers. Conclusion The integration of artificial intelligence with global genomic resources holds substantial promise for advancing precision medicine by enabling more accurate, inclusive, and individualized precision medicine. However, this promise should be interpreted cautiously because many AI genomic models remain dependent on retrospective datasets, limited external validation, and variable reproducibility.
Big data in cancer genomics offer substantial potential to advance precision oncology by enabling more accurate and personalized treatment strategies, however, overcoming technical, ethical, and infrastructural barriers is essential to ensure effective translation into clinical practice and equitable healthcare outcomes.
Nur Vanu, Nur Mohammad, Fahad Ahmed et al.· Computational and Systems On...· 0 citations
A clinically oriented, pipeline-based synthesis of contemporary AI applications in genomic medicine, focusing on factors that determine model robustness and clinical utility, and common sources of failure in real-world genomic AI systems.
Alexandra-Maria Blaga, Răzvan-Octavian Mihuț, A. Treteanu et al.· International Journal of Mol...· 0 citations
Introduction: The digital transformation of healthcare is accelerating, driven by unprecedented advancements in Artificial Intelligence (AI). From large language models (LLMs) to biomolecular structure prediction, AI is redefining modern diagnostic and therapeutic standards.
Aim: This review evaluates the current state of AI applications in medicine, focusing on clinical knowledge encoding, molecular drug discovery, and administrative workflow optimization, while critically addressing the technical, ethical, and systemic challenges of their institutional implementation.
Materials and Methods: A structured analysis was conducted utilizing a hybrid approach that combines a multi-decade bibliometric trend perspective with a detailed synthesis of 21 landmark publications, clinical trials, and meta-analyses from high-impact journals.
Results: AI demonstrates expert-level performance in medical knowledge retrieval and spatiotemporal diagnostics. AlphaFold 3 has revolutionized computational therapeutics through all-atom biomolecular interaction prediction, while ambient AI scribes significantly reduce physician burnout by automating clinical documentation workflows. However, data-driven "hallucinations" in LLMs and the inherent "black box" nature of deep learning architectures remain critical barriers to autonomous deployment.
Conclusions: AI is successfully transitioning from an isolated research tool into an essential clinical "co-pilot." Achieving its full potential in Medicine 4.0 requires robust frameworks for algorithmic explainability, global dataset diversification, and a strategic synergy between machine precision and human clinical judgment.
Aleksandra Stańczyk, Kinga Haduch, Zuzanna Michalska et al.· International Journal of Inn...· 0 citations
A conceptual Clinical Co-pilot Framework is proposed to position GenAI as a collaborative partner that supports clinicians rather than replaces them, which provides a conceptual basis for future empirical validation and may help inform the responsible implementation of GenAI in healthcare.
Lina Cheng, Chia-Yu Hung, Te-Nien Chien· International Journal of Adv...· 0 citations
Current evidence indicates that LLMs have substantial potential to enhance healthcare delivery, research, and personalized medicine, but they should currently be regarded as supportive tools rather than autonomous clinical decision-makers.
Antoni Klamka, Paulina Kawalec, Kamil Bronikowski et al.· 0 citations